Biological Information
Background Information:
The PathHunter® PD-L1/PD-L1 Dimerization cell line is a stable, engineered cell line for use in studying drug candidates (small molecules or biologics) targeting receptor-receptor interaction. This cell line enables assessment of ligand (e.g. anti PD-L1 antibody) induced dimerization of PD-L1/PD-L1 receptors. This product uses EFC technology. The cell line included overexpresses PD-L1 target protein fused to PK alongside PD-L1 target protein fused to EA. Upon ligand-induced dimerization of PD-L1/PD-L1 , detectable EFC signal is produced.
This stable engineered cell line is provided as two vials of cryopreserved cells.
Target Class:
Checkpoint Receptor
Family:
IgSF
Sub Family:
Immune Inhibitory Receptor Ligand
Protein Name:
PD-L1
Protein Aliases:
PDCD1 ligand 1|CD274 molecule|B7 homolog 1|B7-H1|CD antigen CD274
Accession Number:
NM_014143.3
UniProt Number:
Q9NZQ7
Gene Name:
CD274
Gene ID:
29126
Gene Aliases:
B7H1|PDCD1L1|PDCD1LG1|PDL1
Target Species:
Human
Cell Background:
U2OS
Usage
Product Type:
Stable Cell Lines
Application:
Drug Discovery & Development
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Cell Based
Assay Measures:
Dimerization
Detection Method:
Chemiluminescence
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
PathHunter®